Stock PRDS PARDES BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pardes Biosciences Goes Public Following Merger With Blank Check Firm FS Development
MT
FS II : Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19 - Form 8-K
PU
PARDES BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
FS Development Corp. II(NasdaqCM:FSII) dropped from NASDAQ Composite Index
CI
PARDES BIOSCIENCES, INC. : Regulation FD Disclosure (form 8-K)
AQ
FS DEVELOPMENT CORP. II : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)
AQ
Pardes Biosciences, Inc. completed the acquisition of FS Development Corp. II from FS Development Holdings II, LLC, Daniel Dubin, Owen Hughes, Deepa Pakianathan, and others in a reverse merger transaction.
CI
FSII and Pardes Biosciences Move Towards Merger With the Goal of Tackling COVID-19 via an Oral Antiviral for Treatment and Prevention of SARS-CoV-2 Infections
BU
FS II : FSII and Pardes Biosciences Move Towards Merger with the Goal of Tackling COVID-19 Via an Oral Antiviral for Treatment and Prevention of SARS-CoV-2 Infections - Form 8-K
PU
FS DEVELOPMENT CORP. II : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
FS II : Material Event - Form 8-K
PU
FS DEVELOPMENT CORP. II : Other Events (form 8-K)
AQ
FS Development Corp. II Registration Statement for Merger with Pardes Declared Effective by SEC
MT
FS Development II : Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021 - Form 8-K
PU
FS DEVELOPMENT CORP. II : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
FS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021
BU
FS DEVELOPMENT CORP. II Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
AQ
FS DEVELOPMENT CORP. II : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
FS DEVELOPMENT CORP. II : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
FS DEVELOPMENT CORP. II Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRDS Stock
  4. News Pardes Biosciences, Inc.